Evidence map›Paper›PMID 31018621›Full record

ArticleCancers2019

HNRNPL Restrains

Sara Pagotto, Angelo Veronese, Alessandra Soranno, Veronica Balatti, Alice Ramassone, Paolo E Guanciali-Franchi, Giandomenico Palka, Idanna Innocenti, Francesco Autore, Laura Z Rassenti and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Role of microRNAs in Chronic Lymphocytic Leukemia.International journal of molecular sciences · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. [BUB1 gene is highly expressed in gastric cancer:analysis based on Oncomine database and bioinformatics].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Sara PagottoAgeing Research Center and Translational medicine-CeSI-MeT, 66100 Chieti, Italy. sara.pagotto@unich.it.
Angelo VeroneseAgeing Research Center and Translational medicine-CeSI-MeT, 66100 Chieti, Italy. a.veronese@unich.it.ORCID 0000-0002-1451-1392
Alessandra SorannoDepartment of Medical, Oral and Biotechnological Sciences, "G. d'Annunzio" University Chieti-Pescara, 66100 Chieti, Italy. alessandra.soranno@gmail.com.
Veronica BalattiDepartment of Cancer Biology and Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA. Veronica.Balatti@osumc.edu.
Alice RamassoneAgeing Research Center and Translational medicine-CeSI-MeT, 66100 Chieti, Italy. alice.ramassone@unich.it.
Paolo E Guanciali-FranchiDepartment of Medical, Oral and Biotechnological Sciences, "G. d'Annunzio" University Chieti-Pescara, 66100 Chieti, Italy. paolo.guanciali@unich.it.
Giandomenico PalkaDepartment of Medical, Oral and Biotechnological Sciences, "G. d'Annunzio" University Chieti-Pescara, 66100 Chieti, Italy. giandomenico.palka@unich.it.
Idanna InnocentiInstitute of Hematology, Catholic University of the Sacred Heart, 00168 Rome, Italy. idanna.innocenti@yahoo.it.
Francesco AutoreInstitute of Hematology, Catholic University of the Sacred Heart, 00168 Rome, Italy. francesco_autore@yahoo.it.
Laura Z RassentiDepartment of Medicine, Moores Cancer Center, University of California at San Diego, La Jolla, CA 92093, USA. lrassenti@ucsd.edu.
Thomas J KippsDepartment of Medicine, Moores Cancer Center, University of California at San Diego, La Jolla, CA 92093, USA. tkipps@ucsd.edu.
Renato Mariani-CostantiniAgeing Research Center and Translational medicine-CeSI-MeT, 66100 Chieti, Italy. rmc@unich.it.ORCID 0000-0002-4440-1848
Luca LaurentiInstitute of Hematology, Catholic University of the Sacred Heart, 00168 Rome, Italy. Luca.Laurenti@unicatt.it.
Carlo M CroceDepartment of Cancer Biology and Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA. Carlo.Croce@osumc.edu.
Rosa VisoneAgeing Research Center and Translational medicine-CeSI-MeT, 66100 Chieti, Italy. r.visone@unich.it.
University of Chieti-Pescara · ITUniversità Cattolica del Sacro Cuore · ITCancer Genetics (United States) · USUniversity of California San Diego · US

Funding

Cancer Gene Discovery to Identify Targetable TargetsR35CA197706 · NCI · OHIO STATE UNIVERSITY · PI CROCE, CARLO M · 2015 to 2021
$6.4M
Biologic and Therapeutic Significance of miR-155 in AMLR01CA201184 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI CROCE, CARLO M, GARZON, RAMIRO · 2016 to 2020
$2.7M
Associazione Italiana per la Ricerca sul Cancro 10054National Cancer Institute R35CA197706NCI NIH HHS R01 CA201184NCI NIH HHS R35 CA197706
6 · The paper itself

Abstract

Aneuploidy and overexpression of

Indexed as

BUB1CINCLL and microRNAHNRNPLmiR-155

Identifiers

PMID31018621
PMCPMC6520824
OpenAlexW2942137626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.